Company intelligence
Informa Connect Life Sciences
About Informa Connect Life Sciences
Informa Connect Life Sciences (formerly KNect 365 Life Sciences, IBC Life Sciences and IIR Pharma) provides the industry with opportunities to connect with the right people, ideas, data and technology to fast-track therapeutic developments, maximize commerciality and improve patient outcomes. KNect365 Life Sciences is a global community of Scientists, Executives, Regulators, Technologists and Academics. Covering everything from pharmaceuticals and biopharma to healthcare and wellness, our global and broad market reach touches all the critical points on the pharma value chain from bench to bedside. The deep relationship we have with our customers, coupled with our in depth industry knowledge, allows us to deliver custom solutions and memorable experiences that meet the ever changing needs of our clients. Our unique content and unrivalled networking opportunities play a vital role in moving individuals, companies and the industry forward.
Verified activity
Signals from Informa Connect Life Sciences
5 published signals
Presence & Recognition
Informa Connect Life Sciences announced the launch of the Cell & Gene Therapy International Europe 2026 Start-Up Zone on the exhibition floor at the Cell & Gene Therapy International Europe exhibition in Berlin, Germany.
Reported by Catherine Simpson
Presence & Recognition
Informa Connect Life Sciences announced that CTO/CSO Shiran Shapira will provide a case study on EXO-CD24, an investigational inhaled exosome therapy developed by Nano24 to treat hyperinflammation and life-threatening cytokine storms associated with conditions like acute respiratory distress syndrome (ARDS).
Reported by Informa Connect Life Sciences
Presence & Recognition
Informa Connect Life Sciences announced that ConnectMe is now LIVE for BioProcess International 2026 at the Hynes Convention Center in Boston from 22 to 25 September.
Reported by Eden Turner
Presence & Recognition
Informa Connect Life Sciences announced that the opening LNP conference will feature a presentation on strategies for engineering organ and cell-specific LNPs for overcoming biological barriers to enable next-generation genetic medicines.
Reported by Informa Connect Life Sciences
Presence & Recognition
Informa Connect Life Sciences thanked Joana Simões Correia, CEO of Exogenus Therapeutics for her providing her experience when visiting Exosomes Europe.
Reported by Informa Connect Life Sciences